Fig. 1From: Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE studyKaplan-Meier plot for PFS for (A) all patients, (B) MSKCC risk categories, and (C) IMDC risk categories (FAS)Back to article page